Mogroside III-A2

Mogroside III-A2
Product Name Mogroside III-A2
CAS No.: 88901-43-3
Catalog No.: CFN92946
Molecular Formula: C48H82O19
Molecular Weight: 963.15 g/mol
Purity: >=98%
Type of Compound: Triterpenoids
Physical Desc.: Powder
Targets: NO
Source: The fruits of Siraitia grosvenorii Swingle.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $338/5mg
Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Antioxidants.2022, 11(3):491.
  • Biomed Pharmacother.2021, 144:112300.
  • Foods.2022, 11(12):1773.
  • Mol Neurobiol.2021, 58(8):3665-3676.
  • Current Pharmaceutical Analysis2017, 13(5)
  • Emirates Journal of Food and Agriculture.2022, 34(6): 528-536.
  • Phytother Res.2018, 32(12):2551-2559
  • Asian Journal of Chemistry2014, 26(22):7811-7816
  • ACS Omega2020, 5,33,20825-20830
  • Front Neurosci.2019, 13:1091
  • Mogroside III-A1

    Catalog No: CFN92193
    CAS No: 88901-42-2
    Price: $318/10mg
    Mogroside III-A2

    Catalog No: CFN92946
    CAS No: 88901-43-3
    Price: $338/5mg
    Mogroside IIIe

    Catalog No: CFN92945
    CAS No: 88901-37-5
    Price: $268/10mg
    Siamenoside I

    Catalog No: CFN90398
    CAS No: 126105-12-2
    Price: $338/20mg
    Mogroside V

    Catalog No: CFN99937
    CAS No: 88901-36-4
    Price: $40/20mg
    Iso-mogroside V

    Catalog No: CFN92065
    CAS No: 1126032-65-2
    Price: $298/10mg
    11-Oxo-mogroside V

    Catalog No: CFN90365
    CAS No: 126105-11-1
    Price: $198/20mg
    11-Deoxymogroside V

    Catalog No: CFN80166
    CAS No: 1707161-17-8
    Price: $388/20mg
    11-Deoxyisomogroside V

    Catalog No: CFN95288
    CAS No: 1628293-32-2
    Price: $368/10mg
    Mogroside VI

    Catalog No: CFN90436
    CAS No: 89590-98-7
    Price: $620/5mg
    J Nat Prod. 2007 May;70(5):783-8.
    Cucurbitane glycosides from the fruits of Siraitia gros venorii and their inhibitory effects on Epstein-Barr virus activation.[Pubmed: 17477572 ]

    METHODS AND RESULTS:
    Six new cucurbitane glycosides, mogroside II B (2), 11-deoxymogroside III (4), 7-oxomogroside II E (5), 7-oxomogroside V (6), 11-oxomogroside II A1 (7), and 11-oxomogroside IV A (8), and two known but new naturally occurring cucurbitane glycosides, mogroside II-A1 (1) and Mogroside III-A2 (3), were isolated from an ethanol extract of the fruits of Siraitia grosvenorii.
    CONCLUSIONS:
    Upon evaluation of compounds 1-8 for inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), all compounds exhibited inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. In addition, compounds 1-8 showed weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
    2''-O-Galloylquercitrin

    Catalog No: CFN95041
    CAS No: 80229-08-9
    Price: $418/5mg
    Glyasperin C

    Catalog No: CFN95065
    CAS No: 142474-53-1
    Price: $333/5mg
    Complanatoside C

    Catalog No: CFN95144
    CAS No: N/A
    Price: $318/5mg
    1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one

    Catalog No: CFN95171
    CAS No: 87095-77-0
    Price: $318/10mg
    N1,N5,N10-(Z)-tri-p-coumaroylspermidine

    Catalog No: CFN95253
    CAS No: 131086-78-7
    Price: $238/5mg
    Dipsacussaponin C

    Catalog No: CFN95353
    CAS No: 152406-43-4
    Price: $318/5mg
    ZP-amide C

    Catalog No: CFN95362
    CAS No: 412316-38-2
    Price: $318/5mg
    Ganolucidic acid D

    Catalog No: CFN95472
    CAS No: 102607-22-7
    Price: $413/5mg
    New compound 19

    Catalog No: CFN95538
    CAS No: N/A
    Price: $413/5mg
    New compound 21

    Catalog No: CFN95560
    CAS No: N/A
    Price: $413/5mg